+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Dynavax Technologies Corporation - logo

Dynavax is a clinical-stage biopharmaceutical company with multiple product candidates in development for the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. The company’s lead product candidates include HEPLISAV-B, an investigational adult hepatitis B vaccine; and AZD1419, which is in Phase II clinical trial for the treatment of asthma. Dynavax Technologies Corporation was founded in 1996 and is headquartered in Berkeley, California.

Respiratory Disease Vaccine Global Market Report 2024 - Product Thumbnail Image

Respiratory Disease Vaccine Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Global Hepatitis B Therapeutics Market 2024-2028 - Product Thumbnail Image

Global Hepatitis B Therapeutics Market 2024-2028

  • Report
  • June 2024
  • 141 Pages
  • Global
From
Influenza Vaccines Market Report 2023-2033 - Product Thumbnail Image

Influenza Vaccines Market Report 2023-2033

  • Report
  • October 2023
  • 192 Pages
  • Global
From
Hepatitis B Vaccine Market Report and Forecast 2024-2032 - Product Thumbnail Image

Hepatitis B Vaccine Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 160 Pages
  • Global
From
Respiratory Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Respiratory Collaboration and Licensing Deals 2016-2024

  • Report
  • October 2024
  • 250 Pages
  • Global
From
Hepatitis B Virus (HBV) Global Market Report 2024 - Product Thumbnail Image

Hepatitis B Virus (HBV) Global Market Report 2024

  • Report
  • January 2024
  • 175 Pages
  • Global
From
Anti-infective Vaccines Market Report 2023-2033 - Product Thumbnail Image

Anti-infective Vaccines Market Report 2023-2033

  • Report
  • September 2023
  • 303 Pages
  • Global
From
Vaccine Sales Market Report 2023-2033 - Product Thumbnail Image

Vaccine Sales Market Report 2023-2033

  • Report
  • June 2023
  • 364 Pages
  • Global
From
Oligonucleotide Therapy Global Market Report 2024 - Product Thumbnail Image

Oligonucleotide Therapy Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Hepatitis B Vaccines - Global Strategic Business Report - Product Thumbnail Image

Hepatitis B Vaccines - Global Strategic Business Report

  • Report
  • October 2024
  • 182 Pages
  • Global
From
From
Loading Indicator